Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

0.3670
-0.0215-5.53%
Post-market: 0.3662-0.0008-0.22%19:59 EDT
Volume:380.33K
Turnover:138.88K
Market Cap:15.07M
PE:-0.18
High:0.3900
Open:0.3900
Low:0.3532
Close:0.3885
52wk High:2.60
52wk Low:0.2382
Shares:41.06M
Float Shares:33.92M
Volume Ratio:1.36
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0300
EPS(LYR):-2.7049
ROE:-53.47%
ROA:-8.93%
PB:0.24
PE(LYR):-0.14

Loading ...

Scienture Holdings closes USD 11.42 million secured note financing with Streeterville Capital

Reuters
·
May 02

Scienture granted 180-day extension to meet Nasdaq minimum bid price

TIPRANKS
·
Apr 15

Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

GlobeNewswire
·
Apr 15

Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead

GlobeNewswire
·
Apr 06

BRIEF-Scienture Reports Year End 2025 Financial Results And Provides Business Update

Reuters
·
Mar 30

Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%

Reuters
·
Mar 30

SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 30

EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025

Benzinga Earnings
·
Mar 30

Scienture FY25 Revenue $431.6K Vs $136.6K YoY; Net Loss Per Common Share $(2.70) Vs $(5.41) YoY

Benzinga Earnings
·
Mar 30

Scienture Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Mar 27

Scienture Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Mar 20

Scienture Shares Surge 48% After Co Signs Deals to Expand Reach of Opioid Overdose Spray

THOMSON REUTERS
·
Mar 11

Why Is Scienture Holdings Stock (SCNX) Up Today?

TIPRANKS
·
Mar 11

Shares of Scienture up 60.1% Premarket After Co Signs Deals to Expand Reach of Opioid Overdose Spray

THOMSON REUTERS
·
Mar 11

Scienture signs GPO agreements for REZENOPY reaching over 5,000 U.S. institutions

Reuters
·
Mar 11

SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions

GlobeNewswire
·
Mar 11